Results revealed that p-AKT level was significantly up-regulated in three DLBLC cell lines including DHL-16, U2932 and Ly-3, suggesting that the intracellular AKT/mTOR pathway in DLBCL cells was activated (Figure 5). The gene discussed is CD8B; the disease is diffuse large B-cell lymphoma.